DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Adamkewicz JI, Schmitt C, Calatzis A. et al.
Pharmacodynamic data and coagulation biomarkers in persons with hemophilia A (PwHA) with inhibitors: results from the HAVEN 1 emicizumab (ACE910) phase 3 study.
Res Pract Thromb Haemost 2017;
1: 162
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.